Nucleophosmin (NPM) is a nucleus-cytoplasmic shuttling protein that is implicated in centrosome duplication, cell cycle progression and stress response. At the steady state, NPM localizes mainly in the nucleolus, where it forms a complex with different cellular proteins. One-third of acute myeloid leukemias (AML) are characterized by aberrant cytoplasmic localization of NPM, due to mutations within its last coding exon (exon 12) that cause a frameshift and the formation of novel C-termini. We report here our investigations on the molecular basis for the aberrant localization of mutated NPM. Alignment of the C-terminus of the various NPM mutants revealed the obligatory presence of four amino-acid residues that match a CRM1-dependent nuclear export signal (NES). Single alanine-substitutions at these sites provoked nuclear re-localization, while fusion of the mutated C-terminus to a heterologous nuclear protein induced CRM1-dependent cytoplasmic localization. Molecular characterization of one exceptional AML carrying cytoplasmic NPM and germ line exon 12 revealed a somatic mutation in the splicing donor site of exon 9 that caused the formation of a functional NES. It appears, therefore, that AMLs are frequently characterized by gain-of-function mutations of NPM that create functional NES, suggesting that alterations of nuclear export might represent a general mechanism of leukemogenesis and a novel target for therapeutic intervention.
Nucleophosmin (NPM) is a nucleus-cytoplasmic shuttling protein that is implicated in centrosome duplication, cell cycle progression and stress response. At the steady state, NPM localizes mainly in the nucleolus, where it forms a complex with different cellular proteins. One-third of acute myeloid leukemias (AML) are characterized by aberrant cytoplasmic localization of NPM, due to mutations within its last coding exon (exon 12) that cause a frameshift and the formation of novel C-termini. We report here our investigations on the molecular basis for the aberrant localization of mutated NPM. Alignment of the C-terminus of the various NPM mutants revealed the obligatory presence of four amino-acid residues that match a CRM1-dependent nuclear export signal (NES). Single alanine-substitutions at these sites provoked nuclear re-localization, while fusion of the mutated C-terminus to a heterologous nuclear protein induced CRM1-dependent cytoplasmic localization. Molecular characterization of one exceptional AML carrying cytoplasmic NPM and germ line exon 12 revealed a somatic mutation in the splicing donor site of exon 9 that caused the formation of a functional NES. It appears, therefore, that AMLs are frequently characterized by gain-of-function mutations of NPM that create functional NES, suggesting that alterations of nuclear export might represent a general mechanism of leukemogenesis and a novel target for therapeutic intervention. The nucleophosmin (NPM) gene (also known as B23, NO38 or numatrin) is involved in several tumorassociated chromosome translocations, which result in the formation of fusion proteins retaining the amino terminus of NPM (NPM-ALK, NPM-RAR and NPM-MLF1). More recently, mutations of NPM have been described in about 35% of AMLs (Falini et al., 2005) . Nucleophosmin mutations are usually associated with a normal karyotype (85%) and are mutually exclusive with the other AML-associated major genetic abnormalities, suggesting that they represent an initiating event in myeloid leukemogenesis.
A major feature of AMLs carrying mutated NPM is the aberrant cytoplasmic localization of the protein. In our reported series of AMLs with cytoplasmic NPM, 51 of 52 cases were genetically characterized by mutations within the most 3 0 NPM exon (exon 12), which codes for a putative nucleolar localization signal (NoLS) (Zirwes et al., 1997) . Notably, ectopic expression of cDNAs encoding mutated NPM (NPMmut) leads to the same cytoplasmic localization of the protein as in the patient blasts, indicating that the mutation is responsible for the aberrant intracellular distribution of NPM (Falini et al., 2005) .
The cytoplasmic localization of NPMmut is probably critical for its putative leukemogenic function. Nucleophosmin forms a complex with the tumor suppressor p19Arf and is required for its stabilization and proper nucleolar localization (Colombo et al., 2005; Korgaonkar et al., 2005) . The NPMmut, instead, provokes the cytoplasmic delocalization of p19Arf and is unable to protect it from degradation. As a consequence, Arf is unable to initiate a proper p53 response and to induce cell cycle arrest (Colombo et al., Cancer Research, in press) (den Besten et al., 2005) .
The molecular bases for the cytoplasmic localization of NPM are unknown. Twenty-seven different types of mutations at the NPM locus have been described so far, which result in the formation of 14 different mutant proteins (Figure 1a ). They consist of the insertion of short nucleotide stretches (4 or 10 bps) at two different positions in the NPM exon 12 (nucleotides 960 or 965 of the reported cDNA sequence; Figure 1a ). Despite genetic heterogeneity, however, all the mutations cause the same frameshift, and, as a consequence, the resulting 14 different NPMmut proteins possess a novel C-terminus (of nine or 11 amino acids) that shares the same last five amino-acid residues (VSLRK; Figure 1a ). It has been proposed that the new C-terminal sequences in the mutants contains a CRM1-dependent nuclear export signal (NES), which may explain the aberrant accumulation of NPMmut in the cytoplasm (Figure 1a ) (Nakagawa et al., 2005) . This is consistent with our observation that leptomycin B (LMB), a drug that inhibits CRM1-dependent nuclear export, provokes the re-localization of NPMmut in the nucleus (Colombo et al., Cancer Research, in press ). We report here our Figure 1 The most frequent nucleophosmin (NPM) exon 12 mutation (Mut1) creates a functional nuclear export signals (NESs). (a) Alignment of partial DNA and protein sequences of wild-type (Wt) NPM and all NPM mutants (Mut 1-15) so far published. DNA alignment: residues 286-294 from Wt NPM reference cDNA sequence (NM 00002520) were aligned with all NPM variants. A consensus sequence (IUPAC standard) is shown if more than one mutation was found coding for the same C-terminal protein sequence. Insertions or substitutions are indicated in light red. Vertical square dotted lines separate specific codon frames. Protein alignment: region from residues 286 to 294 of the Wt NPM protein was compared with the various mutants C-terminal sequences. The amino-acid residues that match the generic NES consensus (indicated below the alignment) are boxed. X: any amino-acid residue; F: Leucine, Valine, Isoleucine, Phenylalanine or Methionine residues. On the left, publication references where various mutant forms were disclosed are listed: NE (Falini et al., 2005) , D (Dohner et al., 2005) , C (Cazzaniga et al., 2005) , S . (b) Immunofluorescence analysis of mutated NPM (Mut1) and Mut1 proteins carrying individual alanine substitutions (L287A; V291A; V294A; L296A, as indicated). Alanine substitutions were obtained through standard PCR-based mutagenesis protocols (QuickChange Multi Site Directed Mutagenesis Kit; Stratagene), using an HA-Flag-tagged version of the NPMmut1 cDNA as template, and the following primers: L287A: 5 0 -GAG GCT ATT CAA GAT GCC TGT CTG GCA GTG GAG; V291A: 5 0 -GAT CTC TGT CTG GCA GCG GAG GAA GTC TCT TTA; V294A: 5 0 -CTG GCA GTG GAG GAA GCC TCT TTA AGA AAA TAG; L296A: 5 0 -GAG GAA GTC TCT GCA AGA AAA TAG TTT AAA. PCDNA-3 expression vectors for the parental NPMmut1 along with the four mutagenized versions were transfected into NPM null mouse embryo fibroblasts (MEFs) and 48 h. Later cells were fixed in 4% paraformaldehyde and stained with anti-HA primary antibody (SIGMA) and anti-mouse FITC conjugated secondary antibody (green staining), nuclei were counter-stained with 4,6-diamidino-2-phenylindole (DAPI). (c) Intracellular localization of GFP proteins fused with NLS or NLS and NESmut1. A DNA fragment coding for the NLS of the simian virus 40 large T-antigen was cloned into the pEGFP-c1 expression vector (Clontech), in-frame with the GFP longest open reading frame, to obtain an NLS-GFP cDNA. Subsequently, the NES of NPMmut1 (DLCLAVEEVLSRH) was produced by self-annealing of two complementary oligonucleotides containing the last 45 nucleotides of NPMmut1 and cloned in-frame with the NLS of NLS-GFP (NLS-GFP-NESmut1). Both constructs were then transfected into NPM null MEFs. Forty-eight hours post-transfection, cells were treated, or not (as indicated) with LMB for 8 h and fixed. Nuclei were counter-stained with DAPI. Images were captured using a Hamamatsu chilled CCD camera attached to an Olympus fluorescence microscope with Photoshop software.
Functional NES in NPM mutants AR Mariano et al investigations aimed at defining the molecular basis for the cytoplasmic localization of NPM.
We first cloned a full-length mutant NPM cDNA from the blasts of one AML patient with cytoplasmic NPM (not shown) and a duplication of the TCTG tetra nucleotide at positions 956-959. This insertion, which is representative of the most frequent type of NPM mutations found in AMLs, causes a frameshift that substitutes the last seven amino acids (WQWRKSL) of the NPM protein with 11 novel residues (CLA-VEEVSLRK) (Figure 1a ; NPMmut1). To investigate whether the NPM mutation creates a functional NES, we introduced single alanine-substitutions of those amino terminal NPMmut1 residues (L287, V291, V294 and L296) that match the NES consensus sequence (LxxxFxxVxL). HA-tagged constructs were then transfected into mouse embryo fibroblasts (MEFs) derived from NPM null mice (to analyse expression of the NPM mutants in the absence of endogenous NPM) and analysed by direct epifluorescence using anti-HA (Figure 1b) or anti-NPM (not shown) antibodies. As expected, the parental NPMmut was detected mainly in the cytoplasm of transfected cells, while each of the four point-mutants accumulated exclusively in the nucleus (Figure 1b) . Same results were obtained after transfection of the various cDNAs into wild-type (Wt) MEFs (not shown). These data indicate that L287, V291, V294 and L296 are critical for the cytoplasmatic localization of NPMmut1 and suggest that they might be part of a functional NES.
We then investigated whether the putative NES region of NPMmut1 (DLCLAVEEVLSRH; NESmut1) is able to direct nuclear export of a heterologous nuclear protein. To this end, we engineered the green fluorescence protein (GFP) with a nuclear localization signal (NLS-GFP), or the NLS plus the NESmut1 (NLS-GFPNESmut1). While the NLS-GFP protein is mainly localized in the nucleus, the NLS-GFP-NESmut1 is almost exclusively cytoplasmic (Figure 1c) . Notably, treatment with LMB leads to a massive nuclear accumulation of the NLS-GFP-NESmut1 protein (Figure 1c) . Together, these data demonstrate that the NPM mutant contains a de novo CRM1-dependent NES, which is responsible for the aberrant accumulation of NPMmut1 in the cytoplasm.
As mentioned earlier, we have reported a single case of AML (AML#11) carrying cytoplasmic NPM and germ-line NPM exon 12 (Falini et al., 2005) . To investigate whether alternative mechanisms of NPM delocalization are selected by the leukemic phenotype, we molecularly characterized this AML case. Reverse transcriptase-polymerase chain reaction (RT-PCR) cloning and sequencing of the NPM mRNAs revealed expression of the physiological NPM1 transcript (the NPM locus encodes two alternatively spliced transcripts: NPM1 and the less abundant NPM2, which differ for the alternative incorporation of exon 10), and of an unusual transcript formed by the direct assembly of NPM exons 8 to exon 11 (NPM8-11; Figure 2a ). Nucleotide sequence of the NPM1 and NPM8-11 transcripts confirmed the absence of nucleotide variations and revealed that the exon 8-exon 11 junction maintains the NPM longest open reading frame (not shown). Accordingly, the NPM8-11 coding sequence localized in the nucleolus and nucleoplasm, upon expression in NPM null fibroblasts (Figure 2b ), thus indicating that this transcript is not responsible for the cytoplasmic localization of NPM in the AML#11 case. We then searched for mutations of the splicing sites of NPM exon 9, which could impose the unusual NPM8-11 transcript and, possibly, other aberrant transcripts. Strikingly, we found a mutation in the splicing donor site of exon 9, consisting in the loss of 22 nucleotides at the 3 0 end of exon 9 and the presence of 6 new nucleotides (Figure 2c) . Notably, this DNA mutation was heterozygous and no longer present in the bone marrow DNA of the same patient after disease remission (not shown). Furthermore, the absence of a splicing donor site at the new exon 9-intron 9 borders suggests that the mutated allele could transcribe for a mature mRNA that retains intron 9. We tested this hypothesis by RT-PCR using forward primer from NPM exon 1 and reverse primer from exon 10 (F1 and R2; Figure 2a ). Gel electrophoresis analysis of the PCR products obtained from the control RNA revealed a single band of 932 bps, consistent with the amplification of the Wt NPM2 transcript (Figure 2b ; then confirmed by DNA sequence, not shown). The same PCR product was also amplified from the AML#11 RNA, which showed, however, an additional fragment of 1909 bps, consistent with the incorporation of 977 bps of the intron 9 (Figure 2b) . Expression of this transcript (9-retained intron 10; 9-RI-10) was confirmed by RT-PCR, using reverse primer from intron 9 (Figure 2b ; F1-R3 primers). Nucleotide sequence analysis of the 9-RI-10 transcript showed the same mutation as found in the genomic DNA, and revealed a frameshift with a stop codon located at position þ 16 of intron 9 (underlined in Figure 2c ). Strikingly, translation of the 9-RI-10 sequence revealed that the C-terminus contains aminoacid residues that perfectly match the NES consensus sequence (DIKAKMLLLKLS; Figures 2c and 1a) . To test whether the 9-RI-10 mutation generates a functional NES, the full-length 9-RI-10 cDNA was expressed into fibroblasts. Immunofluorescence analysis showed that the 9-RI-10 protein is mainly cytoplasmic, with a pattern that is undistinguishable from that of the more frequent NPMmut1 (see Figures 2d and 1b) . Likewise, LMB treatment relocalized the 9-RI-10 mutant protein (renamed NPMmut15; Figure 1a ) in the nucleus. Finally, cloning of the NPMmut15 NES sequence (DIKAKMLLLKLS) in-frame with the NLS-GFP lead to a CRM1-dependent delocalization of the nuclear GFP into the cytoplasm (Figure 2e ). In conclusion, the AML#11 patient carries a mutation of the exon 9-intron 9 boundary, which, like the most frequent NPM mutation (NPMmut1), creates a functional NES responsible for the cytoplasmic accumulation of the protein. It appears, therefore, that the AML phenotype selects for genetically highly diverse mutations of NPM that, however, all cause frameshifts that delete the NoLS and create functional NES.
NPM is a nucleus-cytoplasmic shuttling protein (Borer et al., 1989) . Consistently, it contains a bipartite NLS and a functional NES, which has been recently shown to be responsible for its shuttling (Wang et al., 2005) . The function of the physiological NES of NPM depends the Ran-Crm1 complex, since it can be inhibited by LMB or by the expression of a Ranbinding protein. However, at the steady state, NPM resides mainly in the nucleus, suggesting that the nuclear import of the protein is more efficient than the nuclear export, or, in other words, that the NPM NLS is functionally more potent than its NES.
The AML-associated NPM mutant, instead, is mainly (in Wt cells) or exclusively (in NPM-null cells) localized in the cytoplasm. Yet, it retains the property of Wt NPM to shuttle between the nucleus and the cytoplasm, as revealed by the fact that leptomycin induces massive accumulation of the NPMmut in the nucleus, regardless of the presence of Wt NPM. It appears, therefore, that the novel NES leads to a markedly more efficient Upper panels: Immunofluorescence analysis of the protein encoded by the NPM8-11 transcript. The full-length cDNA corresponding to the NPM8-11 transcript was isolated from the AML#11 patient RNA by RT-PCR using the F1 (GGT TGT TCT CTG GAG CAG CGT TCT) and R1: GCC AGA TAT CAA CTG TTA CAG primers, cloned in the pCDNA3 plasmid and expressed in NPM null MEFs. At 48 h post-transfection, cells were fixed as described in Figure 1b and stained using a primary antibody against NPM (NPMc). Lower panels: Agarose-gel electrophoresis of the 9-RI-10 and NPM2 transcripts in control and AML#11 patient RNAs. Specific transcripts are arrowed (on the right). The primers used for the RT-PCR analysis are indicated on the left. R2: GGA GAG ACA AAT ATA GTC CAT ACT GAG. R3: AAT TTG AGG GGG GAG ACA AAG TTT. (c) Alignment of genomic sequences corresponding to the NPM exon 9-intron 9 boundaries from Wt and the AML#11 mutated alleles. The Wt and mutated amino-acidic sequence are reported below and above the DNA sequences, respectively. Sequence on gray background represents pairing regions on both alleles, while in light red is evidenced nucleotides substitution and deletion. In yellow, splice donor site in the Wt allele. (d) Immunofluorescence analysis of the NPMmut15 (9-RI-10) protein in the presence (right panels) or absence (left panels) of leptomycin B (LMB). The RT-PCR product representative of the full-length 9-RI-10 transcript was cloned into the pcDNA3.1-FLAG c1 expression vector, in frame with the FLAG epitope, and transfected into NPM null MEFs. At 48 h post-transfection, cells were treated or not with LMB for 8 h and then fixed. Immunoflurescence analysis were carried out as described in Figure 1b and c. (e) Intracellular localization of the NLS-GFP-Mut15 protein, in the presence (right panels) or absence (left panels) of LMB. The NLS-GFP-Mut15 expression vector was engineered as described for the Mut1 in Figure 1c . Expression into NPM null mouse embryo fibroblasts and fluorescence analysis was performed as described in Figure 1c .
Functional NES in NPM mutants AR Mariano et al nuclear export of NPM, causing its accumulation in the cytoplasm at the steady state. This modification of the physiological equilibrium between nuclear and cytoplasmic compartments of NPM in AMLs might be the consequence of the cumulative effect of two NES present in the NPMmut (one physiological and the other created by the mutation). Alternatively, the newly created NES might function more efficiently than the natural one in binding CRM1 and promoting nuclear export. It has been recently demonstrated that artificial NES can be easily isolated using CRM1 as a bindingtrap, they can be very potent and they can function independently of Ran-GTP (super-physiological NES), thus suggesting that physiological NES evolved to be 'weak', in order to guarantee the efficient recycling of the components of the nuclear export machinery (Engelsma et al., 2004) . If the NPM mutant-associated NES was super-physiological, as suggested by its effect on the localization of NPM, it might profoundly influence the export machinery of the cell. Notably, components of the nuclear pore that participate in the regulation of nuclear trafficking are involved in other AML-specific genetic alterations (Slape and Aplan, 2004) , thus suggesting that alterations of nuclear export might represent a general mechanism of leukemogenesis and a novel target for therapeutic intervention.
